查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1888555

全球動物用藥品原料藥生產市場：市場規模、佔有率和趨勢分析（按動物、服務、合成方法、治療領域和地區分類），細分市場預測（2025-2033 年）

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share & Trends Analysis Report By Animal, By Service, By Synthesis, By Therapeutic Category, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

動物用藥品原料藥生產市場概覽

2024年全球動物用藥品原料藥（API）生產市場規模估計為93.3億美元，預計2033年將達到173.6億美元。

預計從 2025 年到 2033 年，該行業將以 7.24% 的複合年成長率成長。該行業的成長是由於外包投資增加、新獸藥的研發、畜牧業的擴張以及動物保健支出的增加。

為了降低成本、提高效率並獲得先進的生產能力，製藥公司擴大將動物用藥品原料藥的生產外包給專業的契約製造組織（CMO）。這種外包模式使公司能夠專注於藥物研發和行銷。這導致市場對高品質、生產前置作業時間短且擴充性的原料藥的需求激增。例如，2024年11月，SeQuent Scientific和Viyash Lifesciences核准了一項策略性合併，合併後的公司將成為全球動物保健領域的領導者，擁有整合後的能力、16個生產基地、強大的研發實力，並可進入150多個國際市場。此次合併預計將增強兩家公司的全球影響力，透過生產製造推動創新，並為整個動物醫療產業提供全面的解決方案。

此外，市場成長的驅動力在於企業不斷增加研發投入，以開發創新原料藥，包括新型藥物和生物製藥。研發重點在於療效、安全性和合規性，從而在競爭激烈的市場中脫穎而出。這最終促成了高價值特種原料藥的開發，改善動物健康並增強市場競爭力。

肉類、乳製品和家禽生產的牲畜數量快速成長，加上寵物飼養者數量的增加，正在推動對動物用藥品的需求。牲畜數量的增加導致疾病易感性上升，因此需要疫苗、抗感染劑和佐劑。製造商正透過增加原料藥的產量和擴大生產設施來應對這一需求。這為原料藥創造了強勁的需求，並刺激了創新、技術應用和策略合作。

此外，受可支配收入成長、寵物擁有率上升和畜牧業生產擴張等因素推動，獸醫保健成本不斷上漲，進而刺激了對預防性和治療性藥物的需求。美國寵物用品協會 (APPA) 的報告顯示，到 2024 年，寵物食品、藥品、獸醫保健產品及其他服務的支出將達到 1,520 億美元。支出激增推動了獸用原料藥的生產和消費成長，促使生產商透過業務擴張、採用先進技術和創新產品開發來滿足不斷成長的市場需求。支出增加也促進了對品管、創新和合規性的投資。因此，不斷上漲的動物保健成本直接推動了獸用原料藥生產市場的擴張和競爭力提升。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章 市場因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/市場展望
  • 市場動態
  • 科技趨勢
  • 定價模式分析
  • 市場分析工具
    • 波特五力分析
    • PESTEL 分析與 SWOT 分析

第4章動物用藥品原料藥生產市場：依動物種類區分的估算與趨勢分析

  • 動物用藥品原料藥生產市場：波動分析（依動物種類分類）
  • 動物用藥品原料藥生產市場：按物種分類的估算與預測（2021-2033 年）
  • 伴侶動物
  • 生產動物

第5章動物用藥品原料藥生產市場：按服務類型分類的估算與趨勢分析

  • 動物用藥品原料藥生產市場：按服務類型分類的差異分析
  • 動物用藥品原料藥生產市場：按服務類型分類的估算與預測（2021-2033 年）
  • 內部
  • 合約外包
    • 合約開發
    • 契約製造

第6章：動物用藥品原料藥生產市場：綜合法估算與趨勢分析

  • 動物用藥品原料藥生產市場：依合成方法分類的差異分析
  • 動物用藥品原料藥生產市場：依合成方法分類的估算與預測（2021-2033 年）
  • 化學原料藥
  • 基於生物學的API
  • 高活性藥物成分（HPAPI）

第7章動物用藥品原料藥生產市場：依治療領域分類的估算與趨勢分析

  • 動物用藥品原料藥生產市場：依治療領域分類的差異分析
  • 動物用藥品原料藥生產市場：按治療領域分類的估算與預測（2021-2033 年）
  • 抗寄生蟲藥物
  • 抗感染劑
  • 非類固醇消炎劑（NSAIDs）
  • 其他

第8章動物用藥品原料藥生產市場：各地區的估算與趨勢分析

  • 市場概覽：按地區
  • 按地區分類的市場佔有率分析（2024 年和 2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第9章 競爭情勢

  • 市場參與企業分類
    • 市場領導
    • 新興企業
  • 市場佔有率/評級分析（熱力圖分析，2024 年）
  • 公司簡介
    • Zoetis
    • Alivira Animal Health Ltd.
    • Ofichem Group
    • Chempro Pharma Pvt. Ltd.
    • Siflon Drugs
    • Qilu Animal Health Products Co., Ltd.
    • Vetpharma
    • SUANFARMA
    • MENADIONA
    • Excel Industries Ltd.
Product Code: GVR-4-68039-328-0

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Summary

The global veterinary active pharmaceutical ingredients manufacturing market size was estimated at USD 9.33 billion in 2024 and is projected to reach USD 17.36 billion by 2033, growing at a CAGR of 7.24% from 2025 to 2033. The industry is growing due to rising investments in outsourcing, R&D of new veterinary products, the expanding livestock industry, and expenditure on animal health.

Pharmaceutical companies increasingly outsource animal health API production to specialized contract manufacturing organizations (CMOs) to reduce costs, improve efficiency, and access advanced manufacturing capabilities. This outsourcing enables firms to focus on R&D and marketing of pharmaceuticals. This surges the demand for high-quality APIs having faster production timelines and enhanced scalability. For instance, in November 2024, SeQuent Scientific and Viyash Lifesciences approved a strategic merger, creating a global animal health leader with integrated capabilities, 16 manufacturing facilities, strong R&D, and access to over 150 international markets. This merger is poised to strengthen their global presence, enhance innovation through manufacturing and deliver comprehensive solutions across the animal healthcare industry.

In addition, rising investments in research and development by companies to create innovative APIs, including novel medications and biologics are boosting market growth. R&D focuses on efficacy, safety, and regulatory compliance, enabling differentiation in a competitive market. This leads to the development of high-value, specialized APIs, improved animal health outcomes, and enhanced market competitiveness.

The surge in livestock numbers for meat, dairy, and poultry production, combined with increasing pet populations, has propelled the need for animal health medications. Higher populations lead to more disease susceptibility, requiring vaccines, anti-infectives, and supportive drugs. Manufacturers respond by producing larger volumes of APIs and expanding production facilities. The effect is a robust demand pipeline for APIs, stimulating innovation, technological adoption, and strategic collaborations.

Furthermore, increasing veterinary healthcare spending, driven by higher disposable income, growing pet ownership, and livestock industry expansion, raises demand for preventive and therapeutic medications. According to the American Pet Products Association report, in 2024, USD 152 billion was spent on pets for food, medicines, vet care products and other services. This surge in spending has driven higher production and consumption of veterinary APIs, encouraging manufacturers to expand operations, adopt advanced technologies, and develop innovative products to meet growing market demand. Higher expenditure encourages investment in quality control, innovation, and regulatory compliance. Thus, rising animal health expenditure directly fuels the expansion and competitiveness of the veterinary API manufacturing market.

Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary active pharmaceutical ingredients manufacturing market report based on service, synthesis, animal, therapeutic category, and region.

  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Companion Animals
  • Production Animals
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • In House
  • Contract Outsourcing
    • Contract Development
    • Preclinical Development
    • Clinical Development
    • Contract Manufacturing
  • Synthesis Outlook (Revenue, USD Million, 2021 - 2033)
  • Chemical Based API
  • Biological API
  • HPAPI
  • Therapeutic Category Outlook (Revenue, USD Million, 2021 - 2033)
  • Antiparasitics
  • Anti-infectives
  • NSAIDs
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Synthesis
    • 1.2.3. Animal
    • 1.2.4. Therapeutic Category
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Commodity Flow Analysis
    • 1.7.2. Model 2: Bottom-Up Analysis
    • 1.7.3. Model 3 Volume-Pricing Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Investments in Outsourcing
      • 3.2.1.2. R&D Of New Veterinary Products
      • 3.2.1.3. Expanding Livestock Industry
      • 3.2.1.4. Expenditure on Animal Health
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory Compliance and High Production Costs
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: By Animal Estimates & Trend Analysis

  • 4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Animal: Segment Dashboard
  • 4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Animal Movement Analysis
  • 4.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
  • 4.4. Companion Animals
    • 4.4.1. Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Production Animals
    • 4.5.1. Production Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: By Service Estimates & Trend Analysis

  • 5.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Service: Segment Dashboard
  • 5.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Service Movement Analysis
  • 5.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates & Forecasts, by Service, 2021 to 2033 (USD Million)
  • 5.4. In House
    • 5.4.1. In House Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 5.5. Contract Outsourcing
    • 5.5.1. Contract Outsourcing Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.5.2. Contract Development
      • 5.5.2.1. Contract Development Market Estimates and Forecasts, 2021 - 2033(USD Million)
      • 5.5.2.2. Preclinical Development
        • 5.5.2.2.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033(USD Million)
      • 5.5.2.3. Clinical Development
        • 5.5.2.3.1. Clinical Development Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.5.3. Contract Manufacturing
      • 5.5.3.1. Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: By Synthesis Estimates & Trend Analysis

  • 6.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Synthesis: Segment Dashboard
  • 6.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Synthesis Movement Analysis
  • 6.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates & Forecasts, by Synthesis, 2021 to 2033 (USD Million)
  • 6.4. Chemical-based API
    • 6.4.1. Chemical-based API Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5. Biological API
    • 6.5.1. Biological API Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.6. HPAPI
    • 6.6.1. HPAPI Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: By Therapeutic Category Estimates & Trend Analysis

  • 7.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Therapeutic Category: Segment Dashboard
  • 7.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Therapeutic Category Movement Analysis
  • 7.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates & Forecasts, by Therapeutic Category, 2021 to 2033 (USD Million)
  • 7.4. Antiparasitics
    • 7.4.1. Antiparasitics Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.5. Anti-infectives
    • 7.5.1. Anti-infectives Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.6. NSAIDs
    • 7.6.1. NSAIDs Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: By Regional Estimates & Trend Analysis

  • 8.1. Region Market Dashboard
  • 8.2. Region Market Share Analysis, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Zoetis
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Alivira Animal Health Ltd.
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Ofichem Group
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Chempro Pharma Pvt. Ltd.
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Siflon Drugs
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Qilu Animal Health Products Co., Ltd.
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Vetpharma
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. SUANFARMA
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. MENADIONA
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Excel Industries Ltd.
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 5 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 6 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 7 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 9 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 10 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 11 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 12 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 13 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 14 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 15 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 16 Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 17 Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 18 Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 19 Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 20 Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 21 Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 22 Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 23 Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 24 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 26 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 27 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 28 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 29 UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 30 UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 31 UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 32 UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 33 Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 34 Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 35 Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 36 Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 37 France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 38 France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 39 France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 40 France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 41 Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 42 Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 43 Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 44 Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 45 Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 46 Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 47 Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 48 Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 49 Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 50 Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 51 Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 52 Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 53 Sweden Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 54 Sweden Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 55 Sweden Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 56 Sweden Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 57 Norway Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 58 Norway Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 59 Norway Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 60 Norway Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 66 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 67 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 68 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 69 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 70 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 71 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 72 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 73 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 74 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 75 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 76 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 77 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 78 Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 79 Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 80 Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 81 Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 82 Thailand Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 83 Thailand Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 84 Thailand Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 85 Thailand Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 86 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 87 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 88 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 89 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 90 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 92 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 93 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 94 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 95 Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 96 Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 97 Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 98 Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 99 Argentina Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 100 Argentina Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 101 Argentina Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 102 Argentina Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 108 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 109 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 110 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 111 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 112 UAE Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 113 UAE Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 114 UAE Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 115 UAE Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 117 Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 118 Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 119 Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 124 Qatar Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 125 Qatar Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 126 Qatar Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 127 Qatar Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)
  • Table 128 Oman Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 129 Oman Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Animal, 2021 - 2033 (USD Million)
  • Table 130 Oman Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Synthesis, 2021 - 2033 (USD Million)
  • Table 131 Oman Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, by Therapeutic Category, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value Chain-Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-Up Approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent Market Outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary Market Outlook, 2024 (USD Billion)
  • Fig. 16 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Service Outlook And Key Takeaways
  • Fig. 20 Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Service Movement Analysis
  • Fig. 21 In House Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Contract Outsourcing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Contract Development Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Preclinical Development Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Clinical Development Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Contract Manufacturing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Animal Outlook And Key Takeaways
  • Fig. 28 Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Animal Movement Analysis
  • Fig. 29 Companion Animals Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Production Animals Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Synthesis Outlook And Key Takeaways
  • Fig. 32 Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Synthesis Movement Analysis
  • Fig. 33 Chemical-based API Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Biological API Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 HPAPI Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Oral Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Topical Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Therapeutic Category Outlook And Key Takeaways
  • Fig. 40 Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Therapeutic Category Movement Analysis
  • Fig. 41 Antiparasitics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Anti-infectives Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 NSAIDs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 MEA Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 UAE Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Qatar Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Oman Veterinary Active Pharmaceutical Ingredients Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)